Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Acquity Group Prices IPO Of 5.5 Mln ADS At $6/ADS - Quick Facts

Acquity Group Limited (AQ: Quote) announced the pricing of its initial public offering of 5.55 million American depositary shares or "ADS" at a price to the public of $6.00 per ADS. The ADSs are expected to commence trading on the NYSE AMEX on April 27th, 2012 under the symbol "AQ."

The underwriters have an option, exercisable for 30 days from April 26th, 2012, to buy up to an additional 833,333 ADSs from the company at the initial public offering price. Citigroup Inc. and Oppenheimer & Co., Inc. acted as lead underwriters. William Blair & Company and First Analysis Securities Corp. acted as co managers in the offering.

Click here to receive FREE breaking news email alerts for Acquity Group Ltd. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Economic confidence in the eurozone picked up in October from a 10-month low, with broad based improvement across sectors, the results of a survey by the European Commission showed Thursday. The economic confidence index rose unexpectedly to 100.7 in October from 99.9 in the prior month. The score was expected to fall to 99.7. Visa Inc., the world's largest payment card processor, said Wednesday that its fourth quarter profit fell 10% from last year, hurt mainly by a hefty litigation provision even as revenue increased 9%. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Stocks saw considerable volatility following the Federal Reserve's monetary policy meeting on Wednesday but maintained a negative bias before closing modestly lower. The losses on the day partly offset the rally seen in the previous session.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.